[Surgical therapy of squamous cell carcinoma of the esophagus--expanded radical intervention].
The analysis of our own patients shows that the so-called en-bloc-esophagectomy does not bear more risks compared to standard esophagectomy or transmediastinal esophagectomy. Lethality and complications are within comparable ranges (n = 147; lethality: I 6.6%, II 7.7%). In 83 patients with squamous cell carcinoma of the thoracic esophagus the analysis of survival time shows a 4-year survival time in 54% for the T 1/2-category. At the same time the prognosis is equal for both N0- and N1-metastasis. This can be seen as a success of the en-bloc resection. The prognosis of the T 3/4-tumor category is much worse.
Siewert
J R
JR
Chirurgische Klinik Technischen Universität München, Klinikum rechts der Isar.
Roder
J D
JD
D002294:Carcinoma, Squamous Cell / Q000601:surgery*; D003131:Combined Modality Therapy; D004938:Esophageal Neoplasms / Q000601:surgery*; D004947:Esophagus / Q000601:surgery; D005500:Follow-Up Studies; D006801:Humans; D008197:Lymph Node Excision; D008207:Lymphatic Metastasis; D011183:Postoperative Complications / Q000401:mortality
Chirurgische Therapie des Plattenepithelcarcinoms des Oesophagus--erweiterte Radikalität.